DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis
Science Advances · 2024
DOI: 10.1126/sciadv.adn7732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Eden Engal und 17 weiteren Autor:innen. Beteiligte Einrichtung: The Lautenberg Center for Immunology and Cancer Research, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew Universit…. Hauptthemen laut MEDLINE: Chromosomal Proteins, Non-Histone, DNA (Cytosine-5-)-Methyltransferases, DNA Methylation, DNA Methyltransferase 3B. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Structural maintenance of chromosomes flexible hinge domain-containing 1 (SMCHD1) is a noncanonical SMC protein and an epigenetic regulator. Mutations in SMCHD1 cause facioscapulohumeral muscular dystrophy (FSHD), by overexpressing DUX4 in muscle cells. Here, we demonstrate that SMCHD1 is a key regulator of alternative splicing in various cell types. We show how SMCHD1 loss causes splicing alterations of DNMT3B, which can lead to hypomethylation and DUX4 overexpression. Analyzing RNA sequencing data from muscle biopsies of patients with FSHD and Smchd1 knocked out cells, we found mis-splicing of hundreds of genes upon SMCHD1 loss. We conducted a high-throughput screen of splicing factors, revealing the involvement of the splicing factor RBM5 in the mis-splicing of DNMT3B. Subsequent RNA immunoprecipitation experiments confirmed that SMCHD1 is required for RBM5 recruitment. Last, we show that mis-splicing of DNMT3B leads to hypomethylation of the D4Z4 region and to DUX4 overexpression. These results suggest that DNMT3B mis-splicing due to SMCHD1 loss plays a major role in FSHD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Lautenberg Center for Immunology and Cancer Research, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Department of Military Medicine and "Tzameret", Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Stem Cell Research Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
- Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
- Department of Neurology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112002, Israel.
ORCID-Profile: Eden Engal, Aveksha Sharma, Uria Aviel, Sarah Juster, Shiri Jaffe-Herman, Ophir Geminder, Gillian Kay, Silvina Epsztejn-Litman, Marc Gotkine, Vincent Mouly, Rachel Eiges, Maayan Salton, Yotam Drier
Zitieren
APA
Engal, E., Sharma, A., Aviel, U., Taqatqa, N., Juster, S., Jaffe-Herman, S., Bentata, M., Geminder, O., Gershon, A., Lewis, R., Kay, G., Hecht, M., Epsztejn-Litman, S., Gotkine, M., Mouly, V., Eiges, R., Salton, M., & Drier, Y. (2024). DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis. Science Advances. https://doi.org/10.1126/sciadv.adn7732
Vancouver
Engal E, Sharma A, Aviel U, Taqatqa N, Juster S, Jaffe-Herman S, et al. DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis. Science Advances. 2024. doi:10.1126/sciadv.adn7732
BibTeX
@article{Engal2024,
author = {Engal, Eden and Sharma, Aveksha and Aviel, Uria and Taqatqa, Nadeen and Juster, Sarah and Jaffe-Herman, Shiri and Bentata, Mercedes and Geminder, Ophir and Gershon, Adi and Lewis, Reyut and Kay, Gillian and Hecht, Merav and Epsztejn-Litman, Silvina and Gotkine, Marc and Mouly, Vincent and Eiges, Rachel and Salton, Maayan and Drier, Yotam},
title = {DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adn7732}
}
EUVIMED